Emerging Immunotherapeutic Agents for the Treatment of Bladder Cancer

Immune Checkpoint Inhibitors in RCC At the conclusion of this activity, participants will be able to: 1. Discuss the current immunotherapy options available for the treatment of RCC. 2. Describe both ...

28 Loka 202031min

The Expanding Role of Immune Checkpoint Inhibitors in MIBC and NMIBC At the conclusion of this activity, participants will be able to: 1. Recognize both historic and newer immunotherapy options in the...

21 Loka 202035min

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline Podcast: Part 1 At the conclusion of this activity, participants will be able to: 1. Analyze breakthrough treatments in the management of advanced and...

14 Loka 202029min

Course Description: The course is centered on reviewing medical management and prevention of kidney stones. A focus is on the AUA guidelines for the medical management of stones. The course is focused...

23 Syys 20201h 26min

Course Description: The diagnosis and management of Male Lower Urinary Tract Symptoms (mLUTS) and benign prostatic hyperplasia (BPH) has evolved dramatically over the past 5 years with changing algori...

26 Elo 20201h 27min

This educational series is supported by an independent educational grant from: AstraZeneca; Merck; Pfizer Inc. CME Available: https://auau.auanet.org/node/29200 Course Description: Over the last sev...

21 Elo 202050min

Join Drs. Brian Matlaga and Ryan Hsi as they share insights into diagnostics, therapeutic options, and treatment outcomes for urinary stone disease. Host: Brian Matlaga, MD, MPH, Johns Hopkins Univer...

19 Elo 202036min

Course Description: This course tackles key controversies in surgical stone disease and elucidates the most current rationale to varying treatments using a case-based scenarios. Two well-known senior ...

12 Elo 20201h 27min